Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial.

× No keyword cloud information.

11 in total

Review 1. Translation-Focused Approaches to GPCR Drug Discovery for Cognitive Impairments Associated with Schizophrenia.

Authors: Cassandra J Hatzipantelis; Monica Langiu; Teresa H Vandekolk; Tracie L Pierce; Jess Nithianantharajah; Gregory D Stewart; Christopher J Langmead
Journal: ACS Pharmacol Transl Sci Date: 2020-10-28

Review 2. Antipsychotic drug treatment for elderly people with late-onset schizophrenia.

Authors: Adib Essali; Ghassan Ali
Journal: Cochrane Database Syst Rev Date: 2012-02-15

Review 3. Mouse pharmacological models of cognitive disruption relevant to schizophrenia.

Authors: Jared W Young; Susan B Powell; Mark A Geyer
Journal: Neuropharmacology Date: 2011-06-29 Impact factor: 5.250

4. Attention shaping: a reward-based learning method to enhance skills training outcomes in schizophrenia.

Authors: Steven M Silverstein; William D Spaulding; Anthony A Menditto; Adam Savitz; Robert P Liberman; Sarah Berten; Hannah Starobin
Journal: Schizophr Bull Date: 2008-01-22 Impact factor: 9.306

Review 5. Ziprasidone versus other atypical antipsychotics for schizophrenia.

Authors: Katja Komossa; Christine Rummel-Kluge; Heike Hunger; Sandra Schwarz; Paranthaman Seth S Bhoopathi; Werner Kissling; Stefan Leucht
Journal: Cochrane Database Syst Rev Date: 2009-10-07

6. Notes from Underground: Are Cognitive-Enhancing Drugs Respecting their Promises?

Authors: Frank Larøi; Andrea Raballo
Journal: Front Psychol Date: 2010-09-30

7. Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study.

Authors: Veena Kumari; Ulrich Ettinger; Seoung Eun Lee; Christine Deuschl; Anantha P Anilkumar; Anne Schmechtig; Philip J Corr; Dominic H Ffytche; Steven C R Williams
Journal: Psychopharmacology (Berl) Date: 2015-05-19 Impact factor: 4.530

8. Reward learning as a potential target for pharmacological augmentation of cognitive remediation for schizophrenia: a roadmap for preclinical development.

Authors: Dean T Acheson; Elizabeth W Twamley; Jared W Young
Journal: Front Neurosci Date: 2013-06-18 Impact factor: 4.677

9. Interaction between COMT rs5993883 and second generation antipsychotics is linked to decreases in verbal cognition and cognitive control in bipolar disorder.

Authors: Stephanie A Flowers; Kelly A Ryan; Zongshan Lai; Melvin G McInnis; Vicki L Ellingrod
Journal: BMC Psychol Date: 2016-04-02

10. Time-varying SMART design and data analysis methods for evaluating adaptive intervention effects.

Authors: Tianjiao Dai; Sanjay Shete
Journal: BMC Med Res Methodol Date: 2016-08-30 Impact factor: 4.615